Amnesia Therapeutics - Pipeline Assessment and Market Forecasts to 2019
NEW YORK, Aug. 16, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Amnesia Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Amnesia Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Summary
GlobalData, the industry analysis specialist, has released its new report, "Amnesia Therapeutics - Pipeline Assessment and Market Forecasts to 2019". The report is an essential source of information and analysis on the global Amnesia Therapeutics market. The report identifies the key trends shaping and driving the global Amnesia Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Amnesia Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
The report provides information on the key drivers and challenges of the Amnesia Therapeutics market. Its scope includes -
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Amnesia Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Amnesia Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Amnesia Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Amnesia Therapeutics market
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Amnesia Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Amnesia Therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What's the next big thing in the global Amnesia Therapeutics market landscape? – Identify, understand and capitalize.
Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Amnesia Therapeutics - Introduction 5
2.1 Overview 5
2.1.1 Types of Amnesia 5
2.2 Etiology 8
2.3 Pathophysiology 9
2.4 Epidemiology 9
2.4.1 Global 9
2.4.2 The US 9
2.4.3 The UK 9
2.4.4 France 10
2.4.5 Germany 10
2.4.6 Pharmaco-economic Burden 10
2.5 Symptoms 10
2.6 Diagnosis 10
2.6.1 Primarily Clinical Evaluation 10
2.6.2 Brain Imaging Tests and Laboratory Tests 11
2.7 Treatment and Management Patterns 11
2.7.1 Psychotherapy 11
2.7.2 Medications or Supplements 11
2.8 Referral Pathway 13
2.9 GlobalData Pipeline Report Guidance 14
3 Amnesia Therapeutics - Market Characterization 15
3.1 Amnesia Therapeutics Market Size 15
3.2 Amnesia Therapeutics Market Size (2006-2011) - Global 15
3.3 Amnesia Therapeutics Market Forecast (2011-2019) - Global 16
3.4 Amnesia Therapeutics Market Size (2006-2011) - The US 17
3.5 Amnesia Therapeutics Market Forecast (2011-2019) - The US 18
3.6 Amnesia Therapeutics Market Size (2006-2011) - France 19
3.7 Amnesia Therapeutics Market Forecast (2011-2019) - France 20
3.8 Amnesia Therapeutics Market Size (2006-2011) - Germany 21
3.9 Amnesia Therapeutics Market Forecast (2011-2019) - Germany 22
3.10 Amnesia Therapeutics Market Size (2006-2011) - Italy 23
3.11 Amnesia Therapeutics Market Forecast (2011-2019) - Italy 24
3.12 Amnesia Therapeutics Market Size (2006-2011) - Spain 25
3.13 Amnesia Therapeutics Market Forecast (2011-2019) - Spain 26
3.14 Amnesia Therapeutics Market Size (2006-2011) - The UK 27
3.15 Amnesia Therapeutics Market Forecast (2011-2019) - The UK 28
3.16 Amnesia Therapeutics Market Size (2006-2011) - Japan 29
3.17 Amnesia Therapeutics Market Forecast (2011-2019) - Japan 30
3.18 Drivers and Barriers 31
3.18.1 Drivers for the Amnesia Therapeutics Market 31
3.18.2 Barriers for the Amnesia Therapeutics Market 31
3.19 Opportunity and Unmet Needs 31
3.20 Key Takeaway 32
4 Amnesia Therapeutics Market - Competitive Assessment 33
4.1 Overview 33
4.2 Strategic Competitor Assessment 33
4.3 Product Profile for the Major Marketed Products in the Amnesia Therapeutics Market 33
4.3.1 SSRI 33
4.3.2 Benzodiazepines 34
4.3.3 Thiamine 34
5 Amnesia Therapeutics - Pipeline Assessment 35
5.1 Overview 35
5.2 Strategic Pipeline Assessment 35
5.3 Pipeline by Phases of Development 35
5.3.1 Phase I Pipeline 35
5.4 Amnesia Therapeutics Market - Pipeline by Mechanism of Action 35
5.5 Technology Trends Analytic Framework 35
6 Amnesia Therapeutics - Clinical Trials Mapping 37
6.1 Clinical Trials by Region/Country 37
6.2 Clinical Trials by Phase 38
6.3 Clinical Trials by Trial Status 39
6.4 Prominent Sponsors 40
7 Amnesia Therapeutics - Strategic Assessment 42
7.1 Key Events Impacting the Future Market 42
7.2 Future Market Competition Scenario 42
8 Appendix 44
8.1 Market Definitions 44
8.2 Abbreviations 44
8.3 Methodology 44
8.3.1 Coverage 44
8.3.2 Secondary Research 45
8.3.3 Forecasting 45
8.3.4 Primary Research 48
8.3.5 Expert Panel Validation 48
8.4 Contact Us 48
8.5 Disclaimer 48
8.6 Bibliography 49
List of Tables
1.1 List of Tables
Table 1: Causes of Amnesia 8
Table 2: Amnesia Therapeutics Market, Global, Revenue, $m, 2006-2011 15
Table 3: Amnesia Therapeutics Market, Global, Forecast, $m, 2011-2019 16
Table 4: Amnesia Therapeutics Market, the US, Revenue, $m, 2006-2011 17
Table 5: Amnesia Therapeutics Market, The US, Forecast, $m, 2011-2019 18
Table 6: Amnesia Therapeutics Market, France, Revenue, $m, 2006-2011 19
Table 7: Amnesia Therapeutics Market, France, Forecast, $m, 2011-2019 20
Table 8: Amnesia Therapeutics Market, Germany, Revenue, $m, 2006-2011 21
Table 9: Amnesia Therapeutics Market, Germany, Forecast, $m, 2011-2019 22
Table 10: Amnesia Therapeutics Market, Italy, Revenue, $m, 2006-2011 23
Table 11: Amnesia Therapeutics Market, Italy, Forecast, $m, 2011-2019 24
Table 12: Amnesia Therapeutics Market, Spain, Revenue, $m, 2006-2011 25
Table 13: Amnesia Therapeutics Market, Spain, Forecast, $m, 2011-2019 26
Table 14: Amnesia Therapeutics Market, the UK, Revenue, $m, 2006-2011 27
Table 15: Amnesia Therapeutics Market, the UK, Forecast, $m, 2011-2019 28
Table 16: Amnesia Therapeutics Market, Japan, Revenue, $m, 2006-2011 29
Table 17: Amnesia Therapeutics Market, Japan, Forecast, $m, 2011-2019 30
Table 18: Amnesia Therapeutics - Phase I Pipeline, 2011 35
Table 19: Amnesia Therapeutics Market, Clinical Trials by Region, 2011 37
Table 20: Amnesia Therapeutics Market, Global, Clinical Trials by Phase of Development, 2011 38
Table 21: Amnesia Therapeutics Market, Global, Clinical Trials by Trial Status, 2011 39
Table 22: Amnesia Therapeutics Market, Global, Clinical Trials by Prominent Sponsors, 2011 41
List of Figures
1.2 List of Figures
Figure 1: MRI Scan of Brain with Wernicke's Encephalopathy 6
Figure 2: Gross Morphological View of Brain in Alcoholism-related Wernicke - Korsakoff Syndrome 7
Figure 3: Treatment Pattern of Wernicke's Encephalopathy 12
Figure 4: Referral Pathway 13
Figure 5: Amnesia Therapeutics Market, Global, Revenue, $m, 2006-2011 15
Figure 6: Amnesia Therapeutics Market, Global, Forecast, $m, 2011-2019 16
Figure 7: Amnesia Therapeutics Market, The US, Revenue, $m, 2006-2011 17
Figure 8: Amnesia Therapeutics Market, the US, Forecast, $m, 2011-2019 18
Figure 9: Amnesia Therapeutics Market, France, Revenue, $m, 2006-2011 19
Figure 10: Amnesia Therapeutics Market, France, Forecast, $m, 2011-2019 20
Figure 11: Amnesia Therapeutics Market, Germany, Revenue, $m, 2006-2011 21
Figure 12: Amnesia Therapeutics Market, Germany, Forecast, $m, 2011-2019 22
Figure 13: Amnesia Therapeutics Market, Italy, Revenue, $m, 2006-2011 23
Figure 14: Amnesia Therapeutics Market, Italy, Forecast, $m, 2011-2019 24
Figure 15: Amnesia Therapeutics Market, Spain, Revenue, $m, 2006-2011 25
Figure 16: Amnesia Therapeutics Market, Spain, Forecast, $m, 2011-2019 26
Figure 17: Amnesia Therapeutics Market, The UK, Revenue, $m, 2006-2011 27
Figure 18: Amnesia Therapeutics Market, the UK, Forecast, $m, 2011-2019 28
Figure 19: Amnesia Therapeutics Market, Japan, Revenue, $m, 2006-2011 29
Figure 20: Amnesia Therapeutics Market, Japan, Forecast, $m, 2011-2019 30
Figure 21: Strategic Competitor Assessment of the Major Marketed Products in Amnesia, 2011 33
Figure 22: Amnesia Therapeutics Pipeline by Phase of Development, 2011 35
Figure 23: Technology Trends Analytic Framework for the Amnesia Therapeutics Pipeline, 2011 36
Figure 24: Technology Trends Analytic Framework for the Amnesia Therapeutics Pipeline - Description, 2011 36
Figure 25: Amnesia Therapeutics Market - Clinical Trials by Region, 2011 37
Figure 26: Amnesia Therapeutics Market, Global, Clinical Trials by Phase of Development, 2011 38
Figure 27: Amnesia Therapeutics Market, Global, Clinical Trials by Trial Status, 2011 39
Figure 28: Amnesia Therapeutics Market, Global, Clinical Trials by Overall Sponsors, 2011 40
Figure 29: Amnesia Therapeutics Market, Global, Clinical Trials by Prominent Sponsors, 2011 40
Figure 30: Amnesia Therapeutics, Drivers and Barriers, 2011 42
Figure 31: Implications for Future Market Competition in the Amnesia Market, 2011 42
Figure 32: GlobalData Market Forecasting Model 47
Companies Mentioned
To order this report:
Therapy Industry: Amnesia Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Check our Industry Analysis and Insights
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article